Home > National Drug Code (NDC) > Clindamycin

Clindamycin - 25021-115-04 - (Clindamycin Phosphate)

Alphabetical Index


Drug Information of Clindamycin

Product NDC: 25021-115
Proprietary Name: Clindamycin
Non Proprietary Name: Clindamycin Phosphate
Active Ingredient(s): 150    mg/mL & nbsp;   Clindamycin Phosphate
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Clindamycin

Product NDC: 25021-115
Labeler Name: Sagent Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090109
Marketing Category: ANDA
Start Marketing Date: 20120515

Package Information of Clindamycin

Package NDC: 25021-115-04
Package Description: 25 VIAL in 1 CARTON (25021-115-04) > 4 mL in 1 VIAL

NDC Information of Clindamycin

NDC Code 25021-115-04
Proprietary Name Clindamycin
Package Description 25 VIAL in 1 CARTON (25021-115-04) > 4 mL in 1 VIAL
Product NDC 25021-115
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Clindamycin Phosphate
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120515
Marketing Category Name ANDA
Labeler Name Sagent Pharmaceuticals
Substance Name CLINDAMYCIN PHOSPHATE
Strength Number 150
Strength Unit mg/mL
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]

Complete Information of Clindamycin


General Information